High Levels of Antibodies to Plasmodium falciparum Liver Stage Antigen-1 in Naturally Infected Individuals in Myanmar |
Lee, Hyeong-Woo
(Division of Malaria and Parasitic Diseases, National Institute of Health, Korea Centers for Disease Control and Prevention)
Moon, Sung-Ung (Division of Malaria and Parasitic Diseases, National Institute of Health, Korea Centers for Disease Control and Prevention) Kim, Yeon-Joo (Division of Malaria and Parasitic Diseases, National Institute of Health, Korea Centers for Disease Control and Prevention) Cho, Shin-Hyeong (Division of Malaria and Parasitic Diseases, National Institute of Health, Korea Centers for Disease Control and Prevention) Lin, Khin (Vector Borne Diseases Control Project, Department of Health) Na, Byoung-Kuk (Department of Parasitology and Institute of Health Sciences, Gyeongsang National University College of Medicine) Kim, Tong-Soo (Division of Malaria and Parasitic Diseases, National Institute of Health, Korea Centers for Disease Control and Prevention) |
1 | Guerin-Marchand C, Druilhe P, Galey B, Londono A, Patarapotikul J, Beaudoin RL, Dubeaux C, Tartar A, Mercereau-Puijalon O, Langsley G. A liver-stage-specific antigen of Plasmodium falciparum characterized by gene cloning. Nature 1987; 329: 164-167 DOI ScienceOn |
2 | Connelly M, King CL, Bucci K, Walters S, Genton B, Alpers MP, Hollingdale M, Kazura JW. T-cell immunity to peptide epitopes of liver-stage antigen 1 in an area of Papua New Guinea in which malaria is holoendemic. Infect Immun 1997; 65: 5082-5087 PUBMED |
3 | John CC, Zickafoose JS, Sumba PO, King CL, Kazura JW. Antibodies to the Plasmodium falciparum antigens circumsporozoite protein, thrombospondin-related adhesive protein, and liverstage antigen 1 vary by ages of subjects and by season in a highland area of Kenya. Infect Immun 2003; 71: 4320-4325 DOI |
4 | Wahlgren M, Berzins K, Perlmann P, Persson M. Characterization of the humoral immune response in Plasmodium falciparum malaria. II. IgG subclass levels of anti-P. falciparum antibodies in different sera. Clin Exp Immunol 1983; 54: 135-142 PUBMED |
5 | Ferreira MU, Kimura EA, Katzin AM, Santos-Neto LL, Ferrari JO, Villalobos JM, de Carvalho ME. The IgG-subclass distribution of naturally acquired antibodies to Plasmodium falciparum, in relation to malaria exposure and severity. Ann Trop Med Parasitol 1998; 92: 245-256 DOI |
6 | Aidoo M, Lalvani A, Allsopp CE, Plebanski M, Meisner SJ, Krausa P, Browning M, Morris-Jones S, Gotch F, Fidock DA, Takiguchi M, Robson KJH, Greenwood BM, Druilhe P, Whittle HC, Hill AVS. Identification of conserved antigenic components for a cytotoxic T-lymphocyte-inducing vaccine against malaria. Lancet 1995; 345: 1003-1007 DOI ScienceOn |
7 | Taylor-Robinson AW. Immunity to liver stage malaria: considerations for vaccine design. Immunol Res 2003; 27: 53-70 DOI ScienceOn |
8 | Na BK, Park JW, Lee HW, Lin K, Kim SH, Bae YA, Sohn WM, Kim TS, Kong Y. Characterization of Plasmodium vivax heat shock protein 70 and evaluation of its value for serodiagnosis of tertian malaria. Clin Vaccine Immunol 2007; 14: 320-322 DOI ScienceOn |
9 | Doolan DL, Hoffman SL. The complexity of protective immunity against liver-stage malaria. J Immunol 2000; 165: 1453-1462 DOI PUBMED |
10 | John CC, Ouma JH, Sumba PO, Hollingdale MR, Kazura JW, King CL. Lymphocyte proliferation and antibody responses to Plasmodium falciparum liver-stage antigen-1 in a highland area of Kenya with seasonal variation in malaria transmission. Am J Trop Med Hyg 2002; 66: 372-378 DOI PUBMED |
11 | Lee HW, Moon SU, Ryu HS, Kim YJ, Cho SH, Chung GT, Lin K, Na BK, Kong Y, Chung KS, Kim TS. Usefulness of the recombinant liver stage antigen-3 for an early serodiagnosis of Plasmodium falciparum infection. Korean J Parasitol 2006; 44: 49-54 과학기술학회마을 DOI ScienceOn |
12 | John CC, Tande AJ, Moormann AM, Sumba PO, Lanar DE, Min XM, Kazura JW. Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children. J Infect Dis 2008; 197: 519-526 DOI ScienceOn |
13 | Fidock DA, Gras-Masse H, Lepers JP, Brahimi K, Benmohamed L, Mellouk S, Guerin-Marchand C, Londono A, Raharimalala L, Meis JF, Langsley G, Roussilhon C, Tartar A, Druilhe P. Plasmodium falciparum liver stage antigen-1 is well conserved and contains potent B and T cell determinants. J Immunol 1994; 153: 190-204 PUBMED |
14 | Wipasa J, Elliott S, Xu H, Good MF. Immunity to asexual blood stage malaria and vaccine approaches. Immunol Cell Biol 2002; 80: 401-414 DOI ScienceOn |
15 | Joshi SK, Bharadwaj A, Chatterjee S, Chauhan VS. Analysis of immune response against T-and B-cell epitopes from Plasmodium falciparum liver stage antigen 1 in rodent malaria models and malaria exposed human subject in India. Infect Immun 2000; 68: 141-150 DOI ScienceOn |
16 | Kurtis JD, Hollingdale MR, Luty AJ, Lanar DE, Krzych U, Duffy PE. Pre-erythrocytic immunity to Plasmodium falciparum: the case for an LSA-1 vaccine. Trends Parasitol 2001; 17: 219-223 DOI ScienceOn |
17 | Hollingdale MR, Aikawa M, Atkinson CT, Ballou WR, Chen GX, Li J, Meis JF, Sina B, Wright C, Zhu JD. Non-CS pre-erythrocytic protective antigens. Immunol Lett 1990; 25: 71-76 DOI ScienceOn |
18 | Orlandi-Pradines E, Penhoat K, Durand C, Pons C, Bay C, Pradines B, Fusai T, Josse R, Dubrous P, Meynard JB, Durand JP, Migliani R, Boutin JP, Druilhe P, Rogier C. Antibody responses to several malaria pre-erythrocytic antigens as a marker of malaria exposure among travelers. Am J Trop Med Hyg 2006; 74: 979-985 PUBMED |
19 | Lin K. Malaria control in Myanmar. In Kano S, Tongol-Rivera P eds, Asian Parasitology Vol. 6. Malaria in Asia. Chiba, Japan. Federation of Asian Parasitologists. 2005, p 123-134 |
20 | Bouharoun-Tayoun H, Druilhe P. Plasmodium falciparum malaria: evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity. Infect Immun 1992; 60: 1473-1481 PUBMED |